Global Antifungal Drugs Market 2017-2021

抗真菌薬の世界市場2017-2021

◆タイトル:Global Antifungal Drugs Market 2017-2021
◆商品コード:IRTNTR11145
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2017年2月10日
◆ページ数:91
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名利用)USD3,500 ⇒換算¥392,000見積依頼/購入/質問フォーム
Five User(~5名利用)USD4,500 ⇒換算¥504,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD5,000 ⇒換算¥560,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、抗真菌薬の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、抗真菌薬の世界市場規模及び予測、種類別分析、地域別分析/市場規模、市場の成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。

About Antifungal DrugsAntifungal drugs are chemical compounds used to kill or inhibit the growth of fungi. These drugs act by various mechanisms such as the inhibition of cell division, the inhibition of cell wall formation, and cell membrane disruption.

Technavio’s analysts forecast the global antifungal drugs market to grow at a CAGR of 3.20% during the period 2017-2021.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global antifungal drugs market for 2017-2021. To calculate the market size, the report considers revenue generated from the sales of branded, generics and OTC drugs used for the treatment and prevention of various fungal infections. The report also considers the revenue to be generated from the sales of drugs that are expected to be launched in the market along with the decline in revenue from the patent expiries of the marketed drugs during the forecast period.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Antifungal Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Pfizer
• Merck
• Astellas Pharma
• Novartis
• Johnson & Johnson

[Other prominent vendors]
• Allergan
• Almirall
• Amgen
• Aqua Pharmaceuticals
• AstraZeneca
• Bayer
• Bristol-Myers Squibb
• Celgene
• Dermira
• Elorac
• F. Hoffmann-La Roche
• Galderma
• Genentech
• GlaxoSmithKline
• Hexima
• Hisamitsu Pharmaceutical
• Incyte
• Mayne Pharma
• MediQuest Therapeutics
• Meiji Seika Pharma
• Merz Pharmaceuticals
• Moberg Pharma
• Mylan Pharmaceuticals
• NanoBio
• NovaBiotics
• Novan
• Nuvo Research
• Polichem
• Promius Pharma
• Sanofi
• Seren Pharmaceuticals
• Sun Pharma
• Taro
• Teva Pharmaceutical
• Theravance Biopharma
• Topica Pharmaceuticals
• Viamet Pharmaceuticals

[Market driver]
• Rising popularity of OTC antifungal drugs for dermal infections
• For a full, detailed list, view our report

[Market challenge]
• Antifungal drug resistance
• For a full, detailed list, view our report

[Market trend]
• Increased funding for antifungal research
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

※You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【資料の目次】

Table of Contents

PART 01: Executive summary

PART 02: Scope of  the report

PART 03: Research Methodology

PART 04: Introduction

Key market highlights

PART 05: Market landscape

Market overview
Five forces analysis

PART 06: Market segmentation by ROA

Global oral antifungal drugs market
Global parenteral antifungal drugs market
Global topical antifungal drugs market

PART 07: Market segmentation by type

Global prescription antifungal drugs market
Global OTC antifungal drugs market

PART 08: Market segmentation by chemical class

PART 09: Geographical segmentation

Antifungal drugs market in Americas
Antifungal drugs market in the US
Antifungal drugs market in EMEA
Antifungal drugs market in Europe
Antifungal drugs market in APAC
Antifungal drugs market in Japan

PART 10: Market drivers

QIDP and other special regulatory designations
Increase in prevalence of infections and environmental changes
Rising popularity of OTC antifungal drugs for dermal infections

PART 11: Impact of drivers

PART 12: Market challenges

Antifungal drug resistance
Increased availability of generics and alternative therapies
Poor patient adherence

PART 13: Impact of drivers and challenges

PART 14: Market trends

Increased funding for antifungal research
Increased focus on combination therapies
Incorporation of novel technology for product development
Strategic alliances and M&A

PART 15: Vendor landscape

Competitive scenario
Other prominent vendors

PART 16: Key vendor analysis

Astellas Pharma
Johnson & Johnson
Merck
Novartis
Pfizer

PART 17: Appendix

List of abbreviations

PART 18: Explore Technavio

[List of Exhibits]

Exhibit 01: Market snapshot of global antifungal drugs market

Exhibit 02: Overview of global antifungal drugs market 2016-2021

Exhibit 03: Global antifungal drugs market snapshot: Developed and emerging markets 2016-2021

Exhibit 04: Global antifungal drugs market 2016-2021 ($ billions)

Exhibit 05: Opportunity analysis in global antifungal drugs market

Exhibit 06: Impact of factors affecting the market 2016 and 2021

Exhibit 07: Impact of key customer segments on global antifungal drugs market 2016

Exhibit 08: Five forces analysis

Exhibit 09: Share of global antifungal drugs by ROA 2016 and 2021

Exhibit 10: Market overview of global oral antifungal drugs market

Exhibit 11: Market overview of global parenteral antifungal drugs market

Exhibit 12: Market overview of global topical antifungal drugs market

Exhibit 13: Global antifungal drugs market segmentation by type 2016

Exhibit 14: Market overview of global prescription antifungal drugs market

Exhibit 15: Market overview of global OTC antifungal drugs market

Exhibit 16: Types of anti-fungal drugs by chemical class

Exhibit 17: Global antifungal drugs market: Segmentation by geography (2016-2021)

Exhibit 18: Global antifungal drugs market segmentation by region: Market growth lifecycle analysis 2016

Exhibit 19: Overview of antifungal drugs market in Americas

Exhibit 20: Antifungal drugs market in Americas 2016-2021 ($ billions)

Exhibit 21: Opportunity analysis in antifungal drugs market in Americas

Exhibit 22: Overview of antifungal drugs market in the US

Exhibit 23: Overview of antifungal drugs market in EMEA

Exhibit 24: Antifungal drugs market in EMEA 2016-2021 ($ billions)

Exhibit 25: Opportunity analysis in antifungal drugs market in EMEA

Exhibit 26: Overview of antifungal drugs market in Europe

Exhibit 27: Overview of antifungal drugs market in APAC

Exhibit 28: Antifungal drugs market in APAC 2016-2021 ($ billions)

Exhibit 29: Opportunity analysis in antifungal drugs market in APAC

Exhibit 30: Overview of antifungal drugs market in Japan

Exhibit 31: Impact of drivers and challenges on global antifungal drugs market

Exhibit 32: Impact of drivers

Exhibit 33: Impact of drivers and challenges

Exhibit 34: Impact of trends in global antifungal drugs market

Exhibit 35: Competitive structure analysis of global antifungal drugs market 2016

Exhibit 36: Competitive analysis of global antifungal drugs market

Exhibit 37: Market penetration of various antifungal drug makers worldwide 2016

Exhibit 38: Astellas Pharma: Key highlights

Exhibit 39: Astellas Pharma: Strength assessment

Exhibit 40: Astellas Pharma: Strategy assessment

Exhibit 41: Astellas Pharma: Opportunity assessment

Exhibit 42: Johnson & Johnson: Key highlights

Exhibit 43: Johnson & Johnson: Strength assessment

Exhibit 44: Johnson & Johnson: Strategy assessment

Exhibit 45: Johnson & Johnson: Opportunity assessment

Exhibit 46: Merck: Key highlights

Exhibit 47: Merck: Strength assessment

Exhibit 48: Merck: Strategy assessment

Exhibit 49: Merck: Opportunity assessment

Exhibit 50: Novartis: Key highlights

Exhibit 51: Novartis: Strength assessment

Exhibit 52: Novartis: Strategy assessment

Exhibit 53: Novartis: Opportunity assessment

Exhibit 54: Pfizer: Key highlights

Exhibit 55: Pfizer: Strength assessment

Exhibit 56: Pfizer: Strategy assessment

Exhibit 57: Pfizer: Opportunity assessment



【資料のキーワード】

抗真菌薬

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[抗真菌薬の世界市場2017-2021] (Global Antifungal Drugs Market 2017-2021 / IRTNTR11145)販売に関する免責事項
[抗真菌薬の世界市場2017-2021] (Global Antifungal Drugs Market 2017-2021 / IRTNTR11145)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆